Vitragan ovine hyaluronidase regulatory update

EMEA accepted for review an MAA for Vitragan to treat vitreous hemorrhage. ISTA expects a decision by 1H07. In 2003, ISTA received an approvable letter from the FDA for the same indication, where the ...